AT-9283, a multi-targeted kinase inhibitor, is used potentially for the treatment of multiple myeloma.

896466-61-8

C19H24ClN7O2

417.89

AT 9283;AT-9283 hydrochloride;AT9283;AT-9283

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years